AQST

Aquestive Therapeutics, Inc. SEC filings

Every EDGAR filing for Aquestive Therapeutics, Inc. (AQST), newest first, with AI summaries and stories.

Ticker
AQST
CIK
1398733
Sector
Biotech and pharma
Latest filing
2d

Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Get an email when Aquestive Therapeutics, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Insider activity

No open-market insider buys in the last 30 days.

Also: 1 open-market sale ($106K).

All AQST insider trades

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  1. ROUTINE4Aquestive Therapeutics, Inc.AQST

    2 insider filings

    Daniel Barber, insider filing for AQST

    Show all 2
    • 4Insider filing for AQST
    • 3New insider at AQST

    Daniel Barber, reporting

  4. ROUTINESCHEDULE 13G/AAquestive Therapeutics, Inc.AQST

    2 13G filings

    Ownership stake disclosure by Douglas K Bratton (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13GOwnership stake disclosure

    Douglas K Bratton, filed by

  31. ROUTINE4Aquestive Therapeutics, Inc.AQST

    6 insider filings

    Timothy E Morris, insider filing for AQST

    Show all 6
    • 4Insider filing for AQST
    • 4Insider filing for AQST
    • 4Insider filing for AQST
    • 4Insider filing for AQST
    • 4Insider filing for AQST
    • 4Insider filing for AQST

    Timothy E Morris, reporting

  41. ROUTINE4Aquestive Therapeutics, Inc.AQST

    3 insider filings

    Peter E. Boyd, insider filing for AQST

    Show all 3
    • 4Insider filing for AQST
    • 4Insider filing for AQST
    • 4Insider filing for AQST

    Peter E. Boyd, reporting

Older filings on EDGAR